Michael A. Mussallem, Chairman & CEO at Edwards Lifesciences Corp (EW), sold 45,650 shares at $77.75 ($2.8M) on 2023-02-14, disclosed to the SEC on 2023-02-14.
Seasonal sale ($2.8M) by Chairman & CEO — this insider has traded EW in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 9,500 | $0 | 0.0% |
| 2 | $76.83 | 16,275 | $1.3M | 45.0% |
| 3 | $76.83 | 16,275 | $1.3M | 45.0% |
| 4 | $77.75 | 3,600 | $280K | 10.1% |
| Total | $60.91 avg | 45,650 | $2.8M | 100% |
| Filing → |
| EW | SELL | 2024-03-04 | $3.7M | — | Filing → |
| EW | SELL | 2024-02-05 | $5.0M | — | Filing → |
| EW | SELL | 2024-01-05 | $2.3M | — | Filing → |